About
- Supports the United Nations Global Compact.
- Component of the Dow Jones Industrial Average.
- Member of The Corporate Council on Africa.
- Corporate member of the Council on Foreign Relations.
Leadership
Richard T. Clark (1946-)
- President of Manufacturing Division (2003-2005); CEO and President (2005-2007); Chairman, President and Chief Executive Officer since 2007.
- Chairman of Pharmaceutical Research and Manufacturers of America.
- Executive Committee of Council on Competitiveness.
- Board of Directors of Project HOPE (2006).
- President (2000-2002); Chairman and CEO (2002-2003) of Medco Health Solutions Inc..
- Executive Vice President/Chief Operating Officer of Merck-Medco Managed Care LLC (1997-2000).
- Senior Vice President, Quality Commercial Affairs (4/1997-5/1997); Senior Vice President, North American Operations (5/1996-3/1997); Vice President, North American Operations (10/1994-5/1996); Vice President, Procurement & Materials Management (1993-1994); Vice President, Materials Management & Management Engineering (1991-1993); Executive Director, Management Engineering, Merck Pharmaceutical Manufacturing Division (1989-1991); Senior Director, Management Engineering, Merck Sharp & Dohme (1986-1989); Director, Operations Improvement (1985-1986); Senior Manager, Industrial Engineering (1984-1985); Manager, Industrial Engineering, West Point (1983-1984); Production Manager, Elkton Pharmaceutical Laboratories (1981-1983); Senior New Products Planner (1978-1981); Quality Control Inspector, Industrial Engineer, Quality Control Analyst, Lead Supervisor-Pharmaceutical Production (1972-1978).
- Lieutenant of U.S. Army (1970-1972).
- M.B.A. from American University (1970).
- B.A. from Liberal Arts, Washington & Jefferson College (1968).
Kenneth C. Frazier
- Executive Vice President and President Global Human Health since 2007.
- Board Member of Cornerstone Christian Academy and Ithaka.
- Member of Council of the American Law Institute, American Bar Association and Council on Foreign Relations.
- Executive Vice President and General Counsel (2006); Senior Vice President and General Counsel (1999-2006); Vice President and Deputy General Counsel (1999); Vice President, Public Affairs and Assistant General Counsel (1997-1998); Vice President, Public Affairs (1994-1996).
- Vice President, General Counsel and Secretary at Astra Merck (1992-1994).
- Bar Admissions at Supreme Court of the United States (2002), Pennsylvania State Bar (1978), U.S. District Court for the Eastern District of Pennsylvania (1978).
- Partner in Litigation Department at Drinker Biddle & Reath (1978-1992).
- J.D., Harvard Law School, 1978.
- B.A., Political Science, Pennsylvania State University, 1975.
Peter N. Kellogg
- Executive vice president and chief financial officer since August 2007. Responsible for leading the relationships with AstraZeneca and DuPont.
- Board of Directors at Metabolix Inc. since 2007.
- Executive Vice President and Chief Financial Officer at Biogen Idec Inc. (2004-2007).
- Executive Vice President and Chief Financial Officer at Biogen Inc. (2000-2003).
- Senior Vice President at PepsiCo E-Commerce (2000).
- Senior Vice President and Chief Financial Officer at Frito Lay International (1998-2000).
- Vice President and Chief Financial Officer at Frito Lay Latin America (1996-1998).
- Vice President and Chief Financial Officer, Central/Eastern Europe & Russia at PepsiCo International (1994-1996).
- Vice President and General Manager, South Franchise Division (1993-1994); Vice President and General Manager, Dallas/Ft Worth Bottling Co (1992-1993); Vice President, CFO, South Division (1991-1992) at Pepsi Cola USA.
- Director of Corporate Planning (1987-1988) and Director Business Planning at Pepsi Cola International (1988-1991).
- Senior Consultant at Booz Allen Hamilton Inc. (1982-1987).
- Senior Consultant at Arthur Andersen and Co (1978-1980).
- MBA in Management from the University of Pennsylvania (1982); B.S. in Engineering from Princeton University (1978).
Peter S. Kim
- Executive Vice President Research and Development (2001-2002); President (2003-2008); Executive Vice President and President of Research Laboratories since 2008.
- Associate Head, Department of Biology (1999-2001), Professor of Biology (1995-2001), Associate Professor of Biology (1992-1995), Assistant Professor of Biology (1988-1992) at The Massachusetts Institute of Technology.
- Investigator (1997-2001) and Assistant Investigator (1990-1993) at Howard Hughes Medical Institute.
- Whitehead Fellow (1985-1988); Member (1992-2001); Board of Directors since 2005 at Whitehead Institute for Biomedical Research.
- Board of Directors at Fox Chase Cancer Center since 2003.
- Member of Oversight Committee, Division on Earth and Life Studies at The National Academies (2006-2008).
- Member of Council, Institute of Medicine at National Academy of Sciences (2006-2008).
- Member of National Academy of Sciences since 1997.
- Fellow of American Academy of Microbiology since 1997.
- Fellow of American Association for the Advancement of Science and Biophysical Society since 1999.
- Member of Korean Academy of Science and Technology since 1999.
- Member of Institute of Medicine at National Academy of Sciences since 2000.
- National Academy of Sciences Award in Molecular Biology (1993), Eli Lilly Award in Biological Chemistry (1994), Dupont Merck Young Investigator Award (1994), Pfizer Animal Health Award (1995), Ho-Am Prize for Basic Science at Samsung Foundation (1998), Hans Neurath Award at Protein Society (1999), Harvey Lecture at The Harvey Society (2002).
- Ph.D. Biochemistry from Stanford University (1985).
- A.B. Chemistry from Cornell University (1979).
Bruce N. Kuhlik
- Executive Vice President and General Counsel since 2008.
- Senior Vice President and General Counsel (2007).
- Vice President and Associate General Counsel (2005-2007).
- Senior Vice President and General Counsel at Pharmaceutical Research and Manufacturers of America (2002-2005).
- Partner (1990-2002) and Associate (1982-1984, 1986-1990) at Covington & Burling.
- Assistant to the Solicitor General at U.S. Department of Justice (1984-1986).
- Law Clerk at Honorable Levin H. Campbell, U.S. Court of Appeals for the First Circuit (1981-1982).
- Bar Admissions at Pennsylvania, Limited In-House Counsel License (2005), Supreme Court of the United States (1985), and District of Columbia (1982).
- J.D. from Harvard Law School (1981).
- A.B. Economics from Harvard College (1978).
Fred Hassan (1945-)
- Chairman of the Board and Chief Executive Officer of Schering-Plough since April 2003.
- Chairman and Chief Executive Officer of Pharmacia Corporation (1997-2003).
- Executive Vice President of Wyeth.
- U.S. pharmaceuticals business at Sandoz Pharmaceuticals (Novartis).
- Board Member of CIGNA Corporation (2001), Avon Products Inc. (1999), Pharmacia & Upjohn (1997), and Wyeth (1995-1997).
- President of International Federation of Pharmaceutical Manufacturers Associations.
- Past Chairman of Board of Directors at Pharmaceutical Research and Manufacturers of America (PhRMA).
- Past Chairman of HealthCare Institute of New Jersey.
- Chairman of Board of Pharmacia (2001).
- B.S. from Chemical Engineering, Imperial College of Science and Technology at University of London.
- M.B.A. from Harvard Business School.
Robert J. Bertolini
- Executive Vice President and Chief Financial Officer of Schering-Plough since 2003.
- PricewaterhouseCoopers.
- Coopers & Lybrand (1983).
- B.A. Economics from Rutgers University.
- Certified Public Accountant.
Corporate Governance
Raymond V. Gilmartin (1941-)
- Chairman, President and Chief Executive (1994-2005).
- Professor at Harvard Business School as Professor of Management Practice teaching in the MBA program since July 2006.
- Board of directors at Microsoft since 2001, General Mills Inc. (1998) and Dean's Advisors for the Harvard Business School.
- Member of American Enterprise Institute, America's Foundation, Bush-Cheney '04, The Business Council, Business Roundtable, Elizabeth Dole Committee, Elizabeth Dole for President, Ensign for Senate, Friends of George Allen, George W. Bush for President, Rely on Your Beliefs Fund, Romney for President, Santorum 2006, Transatlantic Business Dialogue, Tau Beta Pi Engineering Honor Society.
- Stakeholder in the Harvard Program for Health System Improvement, past chair of the Healthcare Leadership Council and board member of the Alliance for Healthcare Reform.
- Past chair of the Pharmaceutical Research and Manufacturers of America and past president of the International Federation of the Pharmaceutical Manufacturers Associations.
- Chairman of United Negro College Fund.
- Member of the President's Export Council and past chair of the Council on Competitiveness.
- Member of the Transatlantic Business Dialogue and of the Trade and Poverty Forum, a project of the German Marshall Fund.
- Chairman, President and CEO of Becton Dickinson (1976-1994).
- At Kodak (1963-1966) and Arthur D. Little (1968-1976).
- BS in electrical engineering from Union College (1963); MBA from Harvard Business School (1968).
Steven F. Goldstone (1945-)
- Board of Directors since September 2007.
- Non-executive chairman of the Board of Directors of ConAgra Foods Inc.
- Chairman of the Founders Hall Foundation Inc. and the Roundabout Theatre Company of New York.
- Trustee of the Aldrich Museum of Contemporary Art.
- Member of the Board of American Standard Companies Inc. (2002-2007), Greenhill & Co. (2004), New Castle Hotels, Retail DNA Inc., Trane (2007).
- Overseer at the University of Pennsylvania.
- Founder of Silver Spring Group.
- Member of Bush-Cheney 2000, Friends of Senator D'Amato 1998 Committee.
- Board of Directors (2004) and Chairman (1999-2000) of Nabisco Group Holdings.
- Chairman and chief executive officer of RJR Nabisco Inc. (1995-2000).
- Graduate of the University of Pennsylvania; Law degree from New York University (1970).
Thomas Henry Glocer (1959-)
- Board of Directors since November 2007.
- Chief Executive Officer of Reuters Group PLC since July 2001 (joined in 1993).
- Member of Hillary Clinton for President and Obama for America.
- Mergers and acquisitions lawyer with Davis Polk & Wardwell in New York, Paris and Tokyo.
- Member of the International Advisory Board of British American Business Inc., the Advisory Board of the Judge Institute of Management at Cambridge University, the European Business Leaders Council, the Corporate Advisory Group of Tate Britain and The Madison Council of the Library of Congress.
- Bachelor's degree in political science from Columbia University; Law degree from Yale Law School.
Leslie A. Brun (1952-)
- Board of Directors since July 2008.
- Chairman and chief executive officer of SARR Group.
- Non-executive chairman of the board of directors of Automatic Data Processing Inc. since 2007 (joined in 2003).
- Board of directors of Philadelphia Media Holdings and Broadridge Financial Solutions Inc.
- Member of Obama for America.
- Member of the Council on Foreign Relations.
- Trustee of the University at Buffalo Foundation Inc.
- Trustee of The Episcopal Academy in Philadelphia.
- Chairman of the U.S. Small Business Administration's S.B.I.C. Advisory Council and member of the Committee for the Reinvention of the S.B.A.
- Founder of Hamilton Lane Advisors Inc. (1991).
- Managing director at Fidelity Bank in Philadelphia where founded the investment banking group.
- At Bankers Trust (1975-1977) and Assistant of Chemical Bank (1977-1982).
- Bachelor's degree from The State University of New York at Buffalo.
Carlos E. Represas
- Board of Directors since February 2009.
- President and CEO of Nestle Group Mexico (1983-1994); Executive vice president and head of the Americas for Nestlé S.A. until 2004.
- Member of the Latin American Business Council and the boards of the Mexican Health Foundation and the Latin American Chamber of Commerce in Switzerland.
- Bachelor's degree in economics from the National University of Mexico.
D. Gary Gilliland, M.D., Ph.D.
- Senior vice president of Merck Research Laboratories and Oncology Franchise Head since March 2009.
- Investigator of the Howard Hughes Medical Institute, director of the Leukemia Program at the Dana-Farber/Harvard Cancer Center, and director of the Cancer Stem Cell Program of the Harvard Stem Cell Institute.
- Elected member of the American Society for Clinical Investigation and the Association of American Physicians.
- Professor of Medicine at Harvard Medical School and Professor of Stem Cell and Regenerative Biology at Harvard University for nearly 20 years.
- Ph.D. in Microbiology from University of California, Los Angeles, and M.D. from the University of California, San Francisco. Internship and residency, including serving as Chief Medical Resident, at Brigham and Women's Hospital, Harvard Medical School. Hematology and Medical Oncology training at the Brigham and Women's Hospital and the Dana-Farber Cancer Institute, respectively.
Former Members
Alan Shaw, Ph.D.
- President & Chief Executive Officer of VaxInnate Corporation.
- Former Executive Director of MVD's Public Policy, Public Health and Medical Affairs Department at Merck Vaccine Research Division.
- Former Executive Director of Virus & Cell Biology at Merck Research Laboratories.
- In the development of a combination measles-mumps-rubella-varicell vaccine (ProQuad), a live oral rotavirus vaccine, (RotaTeq), human papillomavirus vaccine (Gardasil), and zoster vaccine (Zostavax) as well as numerous early-stage experimental vaccines.
- On vaccines for hepatitis B and Plasmodium falciparum as well as cytokines, cell trafficking and natural inhibitors of inteleukin-1 at Biogen S.A., in Geneva, Switzerland.
- Past Chairman of the International Federation of Pharmaceutical Manufacturers Association Biologicals Committee and part time member of the faculty at Temple University.
- Post doctoral fellowships at the International Institute of Cellular Pathology in Brussels and The Rockefeller University.
- B.A. from Rice University; M.S. in molecular biology from the University of Texas at Dallas; Ph.D. in molecular biology at the Medical College of Ohio.